Susquehanna International Group
TNGX icon

Susquehanna International Group’s Tango Therapeutics TNGX Stock Holding History

Susquehanna International Group’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.31M Buy
105,985
+19,635
+23% +$485K ﹤0.01% 5421
2026
Q1 		$1.81M Buy
86,350
+51,134
+145% +$712K ﹤0.01% 6406
2025
Q4 		$312K Sell
35,216
-53,623
-60% -$462K ﹤0.01% 9850
2025
Q3 		$746K Sell
88,839
-153,608
-63% -$1.04M ﹤0.01% 8046
2025
Q2 		$1.24M Buy
242,447
+175,832
+264% +$435K ﹤0.01% 6886
2025
Q1 		$91.3K Buy
66,615
+41,342
+164% +$102K ﹤0.01% 11595
2024
Q4 		$78.1K Buy
25,273
+8,965
+55% +$41.6K ﹤0.01% 11482
2024
Q3 		$126K Buy
16,308
+1,478
+10% +$14.1K ﹤0.01% 10892
2024
Q2 		$127K Sell
14,830
-28,062
-65% -$217K ﹤0.01% 10849
2024
Q1 		$341K Buy
42,892
+16,476
+62% +$177K ﹤0.01% 9419
2023
Q4 		$262K Buy
26,416
+1,578
+6% +$13.7K ﹤0.01% 10118
2023
Q3 		$280K Buy
24,838
+9,190
+59% +$56K ﹤0.01% 9507
2023
Q2 		$52K Sell
15,648
-12,446
-44% -$44.8K ﹤0.01% 11327
2023
Q1 		$111K Buy
+28,094
New +$163K ﹤0.01% 11205
2022
Q4 		– Sell
-13,480
Closed -$49K – 13678
2022
Q3 		$49K Buy
+13,480
New +$57.6K ﹤0.01% 12221
2022
Q2 		– Sell
-332,000
Closed -$2.52M – 13948
2022
Q1 		$2.52M Buy
332,000
+215,120
+184% +$1.86M ﹤0.01% 4966
2021
Q4 		$1.28M Buy
+116,880
New +$1.41M ﹤0.01% 6616

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Susquehanna International Group's TNGX Position: Q2 2026 in Review

Susquehanna International Group increased its Tango Therapeutics (TNGX) stake by 23% in Q2 2026, buying an estimated $485K and bringing the position to 105,985 shares worth $3.31M. The position accounts for ﹤0.01% of the portfolio, ranked #5421.

Susquehanna International Group first reported a position in TNGX in Q4 2021 and has held it in 17 quarters since. 249 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Susquehanna International Group held 105,985 shares of Tango Therapeutics worth $3.31M as of Q2 2026.
  • Susquehanna International Group bought 19,635 Tango Therapeutics shares in Q2 2026, an estimated $485K.
  • Tango Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #5421 holding.
  • Susquehanna International Group first reported a position in Tango Therapeutics in Q4 2021 and has held it in 17 quarters since.
  • 249 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.